Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled, Double-Blinded, Placebo-Controlled Trial to Investigate the Efficacy and Safety of CARDIO® in Adult Asthmatics

NCT05137132 is registered in ClinicalTrials.gov with Hofseth Biocare ASA as lead sponsor.

NCT NCT05137132
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05137132 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled, Double-Blinded, Placebo-Controlled Trial to Investigate the Efficacy and Safety of CARDIO® in Adult Asthmatics
Lead sponsor
Hofseth Biocare ASA
Phase
Not applicable
Overall status
Completed
Start date
April 1, 2022
Completion date
December 9, 2024
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma